Karen O’Rourke

Active 1985–2021

Also published as
Karen O'Rourke
41
Papers
29,161
Citations
39
h-index
40
i10-index

Citations

Citations per year for Karen O’Rourke1979: 1 citations1985: 4 citations1986: 13 citations1987: 21 citations1988: 15 citations1989: 14 citations1990: 18 citations1991: 26 citations1992: 44 citations1993: 34 citations1994: 21 citations1995: 59 citations1996: 312 citations1997: 736 citations1998: 828 citations1999: 732 citations2000: 549 citations2001: 372 citations2002: 271 citations2003: 275 citations2004: 248 citations2005: 228 citations2006: 266 citations2007: 244 citations2008: 260 citations2009: 291 citations2010: 273 citations2011: 324 citations2012: 287 citations2013: 276 citations2014: 218 citations2015: 241 citations2016: 237 citations2017: 288 citations2018: 256 citations2019: 669 citations2020: 788 citations2021: 785 citations2022: 710 citations2023: 581 citations2024: 669 citations2025: 353 citations2026: 13 citations1980–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,820 citing papers, 34.7% of this breakdownChina: 1,981 citing papers, 14.3% of this breakdownGermany: 880 citing papers, 6.3% of this breakdownUnited Kingdom: 704 citing papers, 5.1% of this breakdownJapan: 657 citing papers, 4.7% of this breakdownCanada: 496 citing papers, 3.6% of this breakdownFrance: 470 citing papers, 3.4% of this breakdownAustralia: 445 citing papers, 3.2% of this breakdownSwitzerland: 302 citing papers, 2.2% of this breakdownSouth Korea: 276 citing papers, 2% of this breakdownItaly: 265 citing papers, 1.9% of this breakdownBelgium: 233 citing papers, 1.7% of this breakdown
0%34.7%Other 16.9%

Fields

  • Biochemistry, Genetics and Molecular Biology68.7%
  • Medicine16.8%
  • Immunology and Microbiology10.1%
  • Neuroscience1.4%
  • Agricultural and Biological Sciences1.1%
  • Nursing0.4%
  • Other1.5%

Topics

  • Inflammasome and immune disorders10.8%
  • Cell death mechanisms and regulation9.2%
  • interferon and immune responses4.6%
  • Immune Response and Inflammation4.5%
  • NF-κB Signaling Pathways4.2%
  • Ubiquitin and proteasome pathways2.8%
  • Other63.9%

Coauthors

All papers

Open in search
  1. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2015 cited by 3,743

  2. NINJ1 mediates plasma membrane rupture during lytic cell death

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2021 cited by 849

  3. Cryopyrin activates the inflammasome in response to toxins and ATP

    Authors: , , , , , , , , , - Nature 2006 cited by 3,076

  4. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling

    Authors: , , , , , , , , , , , , - Nature 2004 cited by 1,843

  5. FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex

    Authors: , , , , , , , , , , , , , - Cell 1996 cited by 3,067

  6. IRF2 transcriptionally induces GSDMD expression for pyroptosis

    Authors: , , , , , , , , , , , , , , , , , , - Science Signaling 2019 cited by 185

  7. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2011 cited by 820

  8. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase

    Authors: , , , , , , , , - Cell 1995 cited by 2,393

  9. FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis

    Authors: , , , - Cell 1995 cited by 2,427

  10. The Receptor for the Cytotoxic Ligand TRAIL

    Authors: , , , , , , - Science 1997 cited by 1,778

  11. A Deubiquitinase That Regulates Type I Interferon Production

    Authors: , , , , , , , , , , , , - Science 2007 cited by 454

  12. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival

    Authors: , , , , , , , , , , , , , - Nature 2009 cited by 622

  13. Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 477

  14. Signal Transduction by DR3, a Death Domain-Containing Receptor Related to TNFR-1 and CD95

    Authors: , , , , , , , , , - Science 1996 cited by 654

  15. Human De-Etiolated-1 Regulates c-Jun by Assembling a CUL4A Ubiquitin Ligase

    Authors: , , , , , , - Science 2004 cited by 370

  16. Association of C-Terminal Ubiquitin Hydrolase BRCA1-Associated Protein 1 with Cell Cycle Regulator Host Cell Factor 1

    Authors: , , , , , , , , , - Molecular and Cellular Biology 2009 cited by 216

  17. Bcl10 activates the NF-κB pathway through ubiquitination of NEMO

    Authors: , , , , , , , - Nature 2003 cited by 526

  18. COP1 is a tumour suppressor that causes degradation of ETS transcription factors

    Authors: , , , , , , , , , , , , , , , , , - Nature 2011 cited by 171

  19. Caspase-9, Bcl-XL, and Apaf-1 Form a Ternary Complex

    Authors: , , - Journal of Biological Chemistry 1998 cited by 522

  20. FADD/MORT1 Is a Common Mediator of CD95 (Fas/APO-1) and Tumor Necrosis Factor Receptor-induced Apoptosis

    Authors: , , , , , , , , - Journal of Biological Chemistry 1996 cited by 774

  21. Interaction of CED-4 with CED-3 and CED-9: A Molecular Framework for Cell Death

    Authors: , , , - Science 1997 cited by 638

  22. Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin.

    Authors: , , , , , , , , - Journal of Biological Chemistry 1990 cited by 376

  23. Identification of Paracaspases and Metacaspases

    Authors: , , , , , , - Molecular Cell 2000 cited by 238

  24. The PYRIN domain: A member of the death domain‐fold superfamily

    Authors: , , , , , , - Protein Science 2001 cited by 153